GAMMA Investing LLC Makes New $768,000 Investment in Intuitive Surgical, Inc. (NASDAQ:ISRG)

GAMMA Investing LLC bought a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 2,277 shares of the medical equipment provider’s stock, valued at approximately $768,000.

Several other hedge funds and other institutional investors have also made changes to their positions in the company. OFI Invest Asset Management purchased a new position in Intuitive Surgical during the third quarter worth approximately $25,000. Baystate Wealth Management LLC grew its stake in shares of Intuitive Surgical by 150.0% in the fourth quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock valued at $25,000 after buying an additional 45 shares in the last quarter. MCF Advisors LLC grew its stake in shares of Intuitive Surgical by 108.1% in the fourth quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock valued at $26,000 after buying an additional 40 shares in the last quarter. Headinvest LLC acquired a new stake in shares of Intuitive Surgical in the third quarter valued at $28,000. Finally, Stone House Investment Management LLC grew its stake in shares of Intuitive Surgical by 100.0% in the third quarter. Stone House Investment Management LLC now owns 100 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 50 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insiders Place Their Bets

In related news, SVP Mark Brosius sold 196 shares of the company’s stock in a transaction that occurred on Tuesday, March 5th. The stock was sold at an average price of $400.00, for a total value of $78,400.00. Following the sale, the senior vice president now owns 1,842 shares in the company, valued at approximately $736,800. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. In other Intuitive Surgical news, Director Alan J. Levy sold 2,000 shares of the stock in a transaction on Friday, January 26th. The stock was sold at an average price of $370.20, for a total transaction of $740,400.00. Following the transaction, the director now owns 25,319 shares of the company’s stock, valued at approximately $9,373,093.80. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, SVP Mark Brosius sold 196 shares of the stock in a transaction on Tuesday, March 5th. The stock was sold at an average price of $400.00, for a total value of $78,400.00. Following the transaction, the senior vice president now directly owns 1,842 shares in the company, valued at approximately $736,800. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 248,418 shares of company stock worth $95,927,097. Company insiders own 0.80% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on ISRG. StockNews.com cut Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Thursday, February 29th. Barclays lifted their target price on Intuitive Surgical from $385.00 to $430.00 and gave the company an “overweight” rating in a report on Thursday, January 25th. Wells Fargo & Company lifted their target price on Intuitive Surgical from $363.00 to $416.00 and gave the company an “overweight” rating in a report on Friday, January 19th. Robert W. Baird decreased their target price on Intuitive Surgical from $440.00 to $436.00 and set an “outperform” rating for the company in a report on Friday. Finally, Jefferies Financial Group lifted their target price on Intuitive Surgical from $365.00 to $375.00 and gave the company a “hold” rating in a report on Friday. Five equities research analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $396.17.

Intuitive Surgical Price Performance

NASDAQ ISRG traded up $8.15 on Tuesday, hitting $377.08. 1,836,588 shares of the company’s stock were exchanged, compared to its average volume of 1,677,112. The firm’s 50-day moving average price is $386.57 and its two-hundred day moving average price is $344.41. Intuitive Surgical, Inc. has a fifty-two week low of $254.85 and a fifty-two week high of $403.76. The firm has a market cap of $133.66 billion, a price-to-earnings ratio of 68.22, a P/E/G ratio of 5.69 and a beta of 1.36.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, April 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.40 by $0.10. Intuitive Surgical had a return on equity of 12.91% and a net margin of 27.16%. The company had revenue of $1.89 billion for the quarter, compared to analysts’ expectations of $1.87 billion. During the same quarter in the previous year, the firm posted $1.00 EPS. The firm’s quarterly revenue was up 11.5% on a year-over-year basis. On average, research analysts predict that Intuitive Surgical, Inc. will post 4.93 earnings per share for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.